Familial neurofibromatosis and hypertrophic cardiomyopathy.

Por Fitzpatrick, A P, Emanuel, R W
Publicado em 1988

QTc dispersion and risk of cardiac death in peripheral vascular disease. Dispersion of 60 ms1/2 is insufficient to change clinical management.

Por Linker, N. J., Fitzpatrick, A. P.
Publicado em 1996

Emergency percutaneous transluminal coronary angioplasty for intractable ventricular arrhythmias associated with acute anterior myocardial infarction.

Por Fitzpatrick, A P, Dawkins, K, Conway, N
Publicado em 1993

Unusual coronary sinus anatomy: the vein of Marshall

Por Fox, D J, Zaidi, A, Fitzpatrick, A P
Publicado em 2005

Financial audit of antitachycardia pacing for the control of recurrent supraventricular tachycardia.

Por Fitzpatrick, A P, Epstein, L M, Lesh, M D
Publicado em 1993

Cardiac tumours simulating collagen vascular disease.

Por Fitzpatrick, A P, Lanham, J G, Doyle, D V
Publicado em 1986

Optimisation of cardiac resynchronisation therapy: addressing the problem of “non-responders”

Por Fox, D J, Fitzpatrick, A P, Davidson, N C
Publicado em 2005

Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.

Por Fitzpatrick, A P, Shapiro, L M, Rickards, A F, Poole-Wilson, P A
Publicado em 1990

Permanent pacing for cardioinhibitory malignant vasovagal syndrome.

Por Petersen, M. E., Chamberlain-Webber, R., Fitzpatrick, A. P., Ingram, A., Williams, T., Sutton, R.
Publicado em 1994

Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial

Por Fitchet, A, Doherty, P J, Bundy, C, Bell, W, Fitzpatrick, A P, Garratt, C J
Publicado em 2003

Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation.

Por Fitzpatrick, A. P., Lee, R. J., Epstein, L. M., Lesh, M. D., Eisenberg, S., Sheinman, M. M.
Publicado em 1996